XML 14 R7.htm IDEA: XBRL DOCUMENT
v3.21.4

STATEMENT OF COMPLIANCE AND BASIS OF PREPARATION | 12 Months Ended
--- | ---
Sep. 30, 2021
Statement Of Compliance And Basis Of Preparation [Abstract] |
STATEMENT OF COMPLIANCE AND BASIS OF PREPARATION [Text Block] | 2. STATEMENT OF COMPLIANCE AND BASIS OF PREPARATION These consolidated financial statements were authorized for issue on December 24, 2021 by the directors of the Company. Statement of compliance These consolidated financial statements have been prepared in accordance with the International Financial Reporting Standards ("IFRS") issued by the International Accounting Standards Board ("IASB") and Interpretations of the International Financial Reporting Interpretations Committee ("IFRIC"). The principal accounting policies applied in the preparation of these financial statements are set out below. Basis of preparation Depending on the applicable IFRS requirements, the measurement basis used in the preparation of these financial statements is cost, net realizable value, fair value or recoverable amount. These financial statements, except for the statement of cash flows, are based on the accrual basis.

X
- References No definition available. + Details
Name: | drug_StatementOfComplianceAndBasisOfPreparationAbstract
Namespace Prefix: | drug_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the basis used for the preparation of the financial statements. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IAS -Number 1 -IssueDate 2020-01-01 -Paragraph 10 -Subparagraph e -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IAS&num=1&code=ifrs-tx-2020-en-r&anchor=para_10_e&doctype=Standard -URIDate 2020-01-01 + Details
Name: | ifrs-full_DisclosureOfBasisOfPreparationOfFinancialStatementsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration